Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 518 for “"CAR T"”.

  1. Κυτταρική θεραπεία CAR T στα λεμφώματα

    … μέσω χιμαιρικών υποδοχέων αντιγόνου Τ κυττάρων (CAR T cells therapy), αποτελεί σύγχρονη θεραπευτική παρέμβαση σε συγκεκριμένους τύπους κακοηθειών. Στην παρούσα μελέτη διερευνάται η δυνατότητα χρήσης και η αποτελεσματικότητα της στα λεμφώματα. Διεξήχθη μια εκτεταμένη και κατά το δυνατόν πλήρης …

    athens Repository record for Κυτταρική θεραπεία CAR T στα λεμφώματα (opens in a new tab)

  2. Super-resolution microscopy of CAR-T cells

    Chimeric antigen receptor (CAR)-T cell therapy represents a transformative approach in cancer immunotherapy, yet the spatial organization and expression dynamics of CARs at the single-molecule level remain poorly understood. This thesis presents the development and application of a novel imaging …

    wurz-thes Repository record for Super-resolution microscopy of CAR-T cells (opens in a new tab)

  3. CAR T-cell Immunotherapy for Brain Tumors

    … Despite an aggressive multimodal standard of care, prognoses and patient quality of life remain exceptionally poor, due in part to the non-specific and toxic nature of conventional treatment options. By contrast, adoptive cell transfer of T cells genetically modified to express tumor-specific …

    duke Repository record for CAR T-cell Immunotherapy for Brain Tumors (opens in a new tab)

  4. CAR-T cell generation via CRISPR-Cas

    … integration of Chimeric Antigen Receptor (CAR) transgenes into the T cell receptor alpha constant (TRAC) locus, effectively reprogramming T cell specificity towards disease-relevant molecular targets. In vivo pre-clinical studies demonstrate that TRAC-targeted CD19-CAR T cells exhibit …

    fu-berlin Repository record for CAR-T cell generation via CRISPR-Cas (opens in a new tab)

  5. CAR-T cell therapy for liver metastases

    … in colorectal cancer patients. The standard of care and potential for cure for colorectal liver metastases is resection, but often times disease it too extensive for this treatment. Over the years, cancer research has made way for advances in treating progressive disease through immunotherapy. …

    bu Repository record for CAR-T cell therapy for liver metastases (opens in a new tab)

  6. Translational Advances in CAR-T Therapy: from clinical validation of an academic CAR-T cell to post-infusion biomarker discovery

    … con receptores de antígenos quiméricos (CAR-T) ha revolucionado el tratamiento de neoplasias hematológicas, especialmente en pacientes refractarios o en recaída sin opciones terapéuticas. Estas terapias adoptivas han mostrado tasas de respuesta sin precedentes en neoplasias B, destacando …

    sevilla Repository record for Translational Advances in CAR-T Therapy: from clinical validation of an academic CAR-T cell to post-infusion biomarker discovery (opens in a new tab)

  7. Optimising CAR T cell manufacturing for solid cancers

    … cancer therapy uses a patient’s own T cells to carry a chimeric antigen receptor (CAR) that targets cancer cells as a key fits a lock. Once targeted, the CAR-T cells kill cancer cells. Although CAR-T cell therapy is a standard treatment for some blood cancers, it has been less successful in …

    adelaide Repository record for Optimising CAR T cell manufacturing for solid cancers (opens in a new tab)

  8. Pharmacological control of CAR T-cells by dasatinib

    … therapies using chimeric antigen receptor (CAR) modified T cells to eradicate tumor cells have been a major breakthrough in the treatment of hematologic malignancies. However, there are no measures to control CAR T cell activity after infusion, which is mostly required in cases of CAR T cell …

    wurz-thes Repository record for Pharmacological control of CAR T-cells by dasatinib (opens in a new tab)

  9. Jnk Signaling Impacts Car-T Cell Effector Function

    … against cancers. Chimeric antigen receptor (CAR) T cell therapy represents a strategy for harnessing T cells against advanced tumors. CAR-T cell therapy has seen striking success against hematologic malignancies, prompting its application to new diseases. Ovarian cancer is a highly lethal …

    uab Repository record for Jnk Signaling Impacts Car-T Cell Effector Function (opens in a new tab)

  10. Β-κυτταρική λεμφοβλαστική λευχαιμία: θεραπευτικό σχήμα. Ανοσοθεραπεία με CAR-T cells / B-cell lymphoblastic leukemia: therapeutic regimen and CAR-T cells immunotherapy

    … αντιγονικού υποδοχέα [chimeric antigen receptor (CAR) T-cell] έχει αναδειχθεί ως μια αποτελεσματική ανοσοθεραπευτική επιλογή, οδηγώντας σε ύφεση πολυθεραπευμένους ασθενείς με B-ALL μέσω της στόχευσης αντιγόνων των Β λεμφοκυττάρων με την χρήση των γενετικά τροποποιημένων Τ λεμφοκυττάρων. Ωστόσο, η …

    athens Repository record for Β-κυτταρική λεμφοβλαστική λευχαιμία: θεραπευτικό σχήμα. Ανοσοθεραπεία με CAR-T cells / B-cell lymphoblastic leukemia: therapeutic regimen and CAR-T cells immunotherapy (opens in a new tab)

  11. OPTIMIZING INTERMEMBRANE DISTANCES TO ENHANCE CAR T-CELL RESPONSIVENESS

    Chimeric Antigen Receptors (CARs) are synthetic molecules that enable T-cells to induce cytotoxicity against tumor cells following recognition of their target cell surface antigen. While this therapy has achieved durable remissions for some leukemia patients, others have relapse driven by the …

    jhu Repository record for OPTIMIZING INTERMEMBRANE DISTANCES TO ENHANCE CAR T-CELL RESPONSIVENESS (opens in a new tab) Embargoed until 2028-08-01

  12. Microfluidic-assisted viral transduction for CAR T-cell manufacture

    Chimeric antigen receptor T-cell therapy improves the patient's T-cell immune response for detecting and eliminating cancer cells using a gene modification process called viral transduction. Unfortunately, current transduction methods are limited in scale and efficiency, making the therapy …

    adelaide Repository record for Microfluidic-assisted viral transduction for CAR T-cell manufacture (opens in a new tab)

  13. Präklinische Studien zur Toxizitätsbegrenzung von SLAMF7 CAR T-Zellen

    Die CAR T-Zelltherapie hat mittlerweile einen festen Platz in der Routine der Onkologie gefunden, was den Umgang mit Nebenwirkungen wie CRS, ICANs, Aplasien und anderen dringlicher macht. Verschiedene Strategien wie degradierbare CARs, duale Rezeptoren oder „Sicherheits-Schalter“ werden bereits …

    wurz-thes Repository record for Präklinische Studien zur Toxizitätsbegrenzung von SLAMF7 CAR T-Zellen (opens in a new tab)

  14. Frβ-Directed Car T Cells for Immunotherapy of Cancer

    T-cells expressing chimeric antigen receptors (CARs) can elicit dramatic clinical responses in CD19+ malignancies; however, therapeutic options for acute myeloid leukemia (AML) and solid tumors remain limited. Folate receptor beta (FRβ) is a myeloid-lineage antigen expressed in 70% of AML. Here, we …

    penn Repository record for Frβ-Directed Car T Cells for Immunotherapy of Cancer (opens in a new tab)

  15. Ionizable lipid nanoparticles for mRNA CAR T cell engineering

    Chimeric antigen receptor (CAR) T cell immunotherapy is FDA approved for the treatment of many blood cancers including acute lymphoblastic leukemia (ALL), large B cell lymphoma, and multiple myeloma with demonstrated success in inducing durable remissions. However, the therapy is also associated …

    penn Repository record for Ionizable lipid nanoparticles for mRNA CAR T cell engineering (opens in a new tab)

  16. CAR T Cell Therapy for the Treatment of Medulloblastoma

    … SHH, Group 3, and Group 4). The standard of care (SoC) for MB patients involves maximal safe tumor resection followed by systemic chemoradiotherapy which can often lead to lifelong neurocognitive impairments in survivors. Group 3 and Group 4 make up the majority of MB patients but are the …

    mcmaster Repository record for CAR T Cell Therapy for the Treatment of Medulloblastoma (opens in a new tab)

  17. Σύγκριση αποτελεσμάτων πέντε ευρωπαϊκών ΗΤΑ για CAR-T θεραπείες

    … πέντε διαφορετικών ΗΤΑ για την αποζημίωση των CAR-T τεχνολογιών ως προς τα κριτήρια για την απόφαση της αποζημίωσης των τεχνολογιών αυτών στην κάθε χώρα αλλά και τα αποτελέσματα της αξιολόγησής τους. Ο σκοπός της εργασίας αυτής είναι κατανοήσουμε, μέσω της συστηματικής βιβλιογραφικής έρευνας, …

    athens Repository record for Σύγκριση αποτελεσμάτων πέντε ευρωπαϊκών ΗΤΑ για CAR-T θεραπείες (opens in a new tab)

  18. Understanding the impact of senescence on CAR-T cell manufacturing

    Chimeric antigen receptor (CAR)-T cell therapy has proven efficacious in hematological malignancies, with success in CD19-targeted therapy for leukemia/lymphoma and B cell maturation antigen (BCMA)-targeted therapy in multiple myeloma. However, a significant portion of patients still relapse …

    ubc Repository record for Understanding the impact of senescence on CAR-T cell manufacturing (opens in a new tab) Download PDF for Understanding the impact of senescence on CAR-T cell manufacturing (opens in a new tab)

Page 1 of 26